Oseltamivir-resistant influenza A viruses circulating in Japan

Journal of Clinical Microbiology

Volumn 47, Issue 5, 2009, Pages 1424-1427

  Tamura, Daisuke ^a   Mitamura, Keiko ^b   Yamazaki, Masahiko ^c   Fujino, Motoko ^d   Nirasawa, Mari ^d   Kimura, Kazuhiro ^e   Kiso, Maki ^a   Shimizu, Hideaki ^f   Kawakami, Chiharu ^g   Hiroi, Satoshi ^h   Takahashi, Kazuro ^h   Hata, Mami ⁱ   Minagawa, Hiroko ⁱ   Kimura, Yoshiaki ^j   Kaneda, Satoko ^j   Sugita, Shigeo ^k   Horimoto, Taisuke ^a   Sugaya, Norio ^l   Kawaoka, Yoshihiro ^a,m  

^a UNIVERSITY OF TOKYO   (Japan)

^b Eijyu General Hospital   (Japan)

^c Zama Children's Clinic   (Japan)

^d SAISEIKAI CENTRAL HOSPITAL   (Japan)

^e Isehara Kyodo Hospital   (Japan)

^f Kawasaki City Institute of Health   (Japan)

^g Yokohama City Institute of Health   (Japan)

^h OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

ⁱ AICHI PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^j Tottori Prefectural Institute of Public Health and Environmental Science   (Japan)

^k EQUINE RESEARCH INSTITUTE   (Japan)

^l Keiyu Hospital   (Japan)

^m UNIVERSITY OF WISCONSIN MADISON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ANTIVIRAL RESISTANCE; ARTICLE; DRUG SENSITIVITY; HUMAN; IC 50; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H1N1 INFECTION; JAPAN; PHYLOGENY; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INHIBITORY CONCENTRATION 50; JAPAN; MUTATION, MISSENSE; NEURAMINIDASE; OSELTAMIVIR; PHYLOGENY; SEQUENCE HOMOLOGY; VIRAL PROTEINS;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 66149098429     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02396-08     Document Type: Article

References (17)

1. Cauchemez, S., A. J. Valleron, P. Y. Boëlle, A. Flahault, and N. M. Ferguson. 2008. Estimating the impact of school closure on influenza transmission from sentinel data. Nature 452:750-754.
2. Centers for Disease Control and Prevention. 2008. Questions & answers: influenza antivirus drug resistance. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/flu/about/qa/antiviralresistance. htm.
3. Gubareva, L. V., R. G. Webster, and F. G. Hayden. 2002. Detection of influenza virus resistance to neuraminidase inhibitors by enzyme inhibition assay. Antivir. Res. 53:47-61. (Pubitemid 33001554)
4. Hatakeyama, S., N. Sugaya, M. Ito, M. Yamazaki, M. Ichikawa, K. Kimura, M. Kiso, H. Shimizu, C. Kawakami, K. Koike, K. Mitamura, and Y. Kawaoka. 2007. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 297:1435-1442.
5. Herlocher, M. L., R. Truscon, S. Elias, H. L. Yen, N. A. Roberts, S. E. Ohmit, and A. S. Monto. 2004. Influenza virus resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J. Infect. Dis. 190:1627-1630.
6. Kiso, M., K. Mitamura, Y. Sakai-Tagawa, K. Shiraishi, C. Kawakami, K. Kimura, F. G. Hayden, N. Sugaya, and Y. Kawaoka. 2004. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364:759-765.
7. Lackenby, A., O. Hungnes, S. G. Dudman, A. Meijer, W. A. Pajet, A. J. Hay, and M. C. Zambom. 2008. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Euro. Surveill. 13:pii=8026.
8. Los Alamos National Laboratory. 2008. The influenza sequence database. Los Alamos National Laboratory, Los Alamos, NM. http://www.flu.lanl.gov/.
9. Portner, A., R. G. Webster, and W. J. Bean. 1980. Similar frequencies of antigenic variants in Sendai, vesicular stomatitis, and influenza A viruses. Virology 104:235-238.
10. Roche. 2005. Media briefing. Roche, Basel, Switzerland.
11. Saito, R., D. Li, Y. Suzuki, I. Sato, H. Masaki, H. Nishimura, T. Kawashima, Y. Shirahige, C. Shimomura, N. Asoh, S. Degawa, H. Ishikawa, M. Sato, Y. Shobugawa, and H. Suzuki. 2007. High prevalence of amantadine-resistance influenza A (H3N2) in six prefectures, Japan, in the 2005-2006 season. J. Med. Virol. 79:1569-1576.
12. Saito, R., Y. Suzuki, D. Li, H. Zaraket, I. Sato, H. Masaki, H. Nishimura, T. Kawashima, S. Hibi, Y. Sano, Y. Shobugawa, T. Oguma, and H. Suzuki. 2008. Increased incidence of adamantane-resistant influenza A (H1N1) and A (H3N2) viruses during the 2006-2007 influenza season in Japan. J. Infect. Dis. 197:630-632.
13. Sheu, T. G., V. M. Deyde, M. Okomo-Adhiambo, R. J. Garten, X Xu, R. A. Bright, E. N. Butler, T. R. Wallis, A. I. Klimov, and L. V. Gubareva. 2008. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 52:3284-3292.
14. Shiraishi, K., K. Mitamura, Y. Sakai-Tagawa, H. Goto, N. Sugaya, and Y. Kawaoka. 2003. High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J. Infect. Dis. 188:57-61. (Pubitemid 36829742)
15. World Health Organization Regional Office for Europe. 2008. Influenza in the European region. World Health Organization, Geneva, Switzerland. http://www.euro.who.int/flu.
16. World Health Organization. 2008. Influenza A (H1N1) virus resistance to oseltamivir - last quarter 2007 to 5 May 2008. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/disease/influenza/ H1N1ResistanceWeb20080417.pdf.
17. Yewdell, J. W., R. D. Webster, and W. U. Gerhard. 1979. Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature 279:246-248.